SE434701B - Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa - Google Patents
Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosaInfo
- Publication number
- SE434701B SE434701B SE7601841A SE7601841A SE434701B SE 434701 B SE434701 B SE 434701B SE 7601841 A SE7601841 A SE 7601841A SE 7601841 A SE7601841 A SE 7601841A SE 434701 B SE434701 B SE 434701B
- Authority
- SE
- Sweden
- Prior art keywords
- interferon
- pseudomonas aeruginosa
- infection prevention
- make tumor
- inducing bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
- Y10S435/875—Pseudomonas aeruginosa
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50055979A JPS51133489A (en) | 1975-05-14 | 1975-05-14 | Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7601841L SE7601841L (sv) | 1976-11-15 |
SE434701B true SE434701B (sv) | 1984-08-13 |
Family
ID=13014183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7601841A SE434701B (sv) | 1975-05-14 | 1976-02-18 | Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa |
Country Status (7)
Country | Link |
---|---|
US (1) | US4079126A (sv) |
JP (1) | JPS51133489A (sv) |
CA (1) | CA1060797A (sv) |
DE (1) | DE2610504C2 (sv) |
FR (1) | FR2311093A1 (sv) |
GB (1) | GB1537509A (sv) |
SE (1) | SE434701B (sv) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1085293A (en) * | 1976-02-05 | 1980-09-09 | Yuzuru Homma | Toxoids derived from protease and elastase of pseudomonas aeruginosa and production thereof |
JPS5296729A (en) * | 1976-02-05 | 1977-08-13 | Shionogi & Co Ltd | Mixed vaccin for cyanomycosis |
US4479935A (en) * | 1980-04-22 | 1984-10-30 | Institut Pasteur | Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation |
CA1256370A (en) * | 1984-02-24 | 1989-06-27 | Yuzuru Homma | Toxoids of elastase of pseudomonas aeruginosa origin |
AT384032B (de) * | 1985-01-14 | 1987-09-25 | Immuno Ag | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) |
US5179001A (en) * | 1985-09-27 | 1993-01-12 | The Regents Of The University Of California | Detection and monitoring of chronic and gram-negative infection |
AT391080B (de) * | 1986-06-24 | 1990-08-10 | Immuno Ag | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen |
US5237053A (en) * | 1986-06-24 | 1993-08-17 | Immuno Aktiengesellschaft | Preparation active against Pseudomonas aeruginosa infections and methods of producing them |
FR2613380B1 (fr) * | 1987-04-06 | 1989-11-17 | Pasteur Institut | Nouvelle substance adjuvante de certains antimitotiques chimiques, procede d'obtention de cette substance a partir de cultures de vibrio cholerae, agents therapeutiques contenant ladite substance |
AU6642390A (en) * | 1989-10-27 | 1991-05-31 | Arch Development Corporation | Methods and compositions for promoting immunopotentiation |
US6406696B1 (en) | 1989-10-27 | 2002-06-18 | Tolerance Therapeutics, Inc. | Methods of stimulating the immune system with anti-CD3 antibodies |
US20030108548A1 (en) * | 1993-06-01 | 2003-06-12 | Bluestone Jeffrey A. | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
US6491916B1 (en) | 1994-06-01 | 2002-12-10 | Tolerance Therapeutics, Inc. | Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies |
SG10201504917PA (en) * | 2005-07-11 | 2015-07-30 | Macrogenics Inc | Methods For The Treatment Of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies With Reduced Toxicity |
BRPI0713426A2 (pt) * | 2006-06-14 | 2012-10-09 | Macrogenics Inc | métodos de tratar, diminuir a progressão, ou melhorar um ou mais sintomas de um distúrbio, e de prevenir ou retardar o inìcio de um distúrbio |
WO2008079713A2 (en) * | 2006-12-21 | 2008-07-03 | Macrogenics Inc. | Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity |
CN103635196B (zh) * | 2011-03-02 | 2019-05-07 | J·深塔格 | 用于单独治疗肝脂肪变性或治疗伴有丙型肝炎病毒感染的肝脂肪变性的组合物、治疗方法和诊断方法 |
CN109401992B (zh) * | 2017-08-18 | 2021-07-23 | 黑龙江省科学院微生物研究所 | 一株高产内毒素蛋白的铜绿假单胞菌及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS496096B1 (sv) * | 1970-09-30 | 1974-02-12 | ||
FR2111719B1 (sv) * | 1970-10-20 | 1975-02-07 | Yuzuru Homma | |
FR2184531B1 (sv) * | 1972-05-19 | 1975-10-17 | Anvar |
-
1975
- 1975-05-14 JP JP50055979A patent/JPS51133489A/ja active Granted
-
1976
- 1976-02-16 GB GB5938/76A patent/GB1537509A/en not_active Expired
- 1976-02-18 SE SE7601841A patent/SE434701B/sv unknown
- 1976-02-26 CA CA246,619A patent/CA1060797A/en not_active Expired
- 1976-03-01 FR FR7605759A patent/FR2311093A1/fr active Granted
- 1976-03-12 DE DE2610504A patent/DE2610504C2/de not_active Expired
- 1976-03-19 US US05/668,564 patent/US4079126A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2311093B1 (sv) | 1979-06-29 |
GB1537509A (en) | 1978-12-29 |
CA1060797A (en) | 1979-08-21 |
DE2610504C2 (de) | 1985-07-11 |
SE7601841L (sv) | 1976-11-15 |
US4079126A (en) | 1978-03-14 |
DE2610504A1 (de) | 1976-11-25 |
JPS6123167B2 (sv) | 1986-06-04 |
FR2311093A1 (fr) | 1976-12-10 |
JPS51133489A (en) | 1976-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE434701B (sv) | Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa | |
SE7610788L (sv) | Zeolit nu-1 och sett att framstella densamma | |
SE7611646L (sv) | Grundmassa och sett att framstella densamma | |
SE414268B (sv) | Muskelskelettknestodmuff och sett att framstella densamma | |
SE427527B (sv) | Rorformigt filterelement och sett att framstella det | |
SE424181B (sv) | Sett att framstella kulformiga aliminiumoxid- innehallande partiklar | |
SE7806122L (sv) | Kontaktlins och sett att framstella densamma | |
SE7601238L (sv) | Sett att behandla avlutar | |
SE7606265L (sv) | Panel och sett att framstella densamma | |
SE7607240L (sv) | Sett att framstella pyrrolettiksyraforeningar | |
FR2320110A2 (fr) | Pansements antiseptiques | |
FR2299761A1 (fr) | Montage d'amplificateur differentiel cmos utilis | |
SE7805269L (sv) | Azolyleterderivat till anvendning som fungicider och sett att framstella foreningarna | |
SE7607004L (sv) | Klisterremsa och sett att tillverka denna | |
SE421185B (sv) | Sett att framstella plastror med muff och plastror framstellt enligt settet | |
SE421695B (sv) | Sett att framstella piperazinylpyraziner | |
SE412488B (sv) | Halvledarkomponentbricka och sett att framstella densamma | |
FR2311210A1 (fr) | Dispositif d'assemblage de deux pieces de bois | |
SE7608887L (sv) | Foreningar av cefalosporin-typ och sett att framstella desamma | |
SE7605650L (sv) | Diskmaskin och sett for att driva densamma | |
SE408649B (sv) | Viskositetsreglerade pigmentkoncentrat och sett att framstella koncentraten | |
SE407594B (sv) | Sett att undvika forgulning och fergtonsforendring vid skrynkeltribehandling av cellulosahaltiga textilmaterial med 1,3-dimetylol-4,5-dihydroxietylenkarbamid | |
SE7601927L (sv) | Nya isocyanater och sett att framstella dessa | |
SE427559B (sv) | Sett att frastella 1-n-(alfa-substituerade-omega-aminoacyl)-3'-deoxiribostamyciner | |
SE7600769L (sv) | Sett att avferga avloppsvatten |